TradingWire.com
HOME • AEON
 
AEON BIOPHARMA, INC.
  
AEON
$1.03
0.17 19.68% 
Open 0.8487   Avg. Volume 259.21k
Previous Close 0.864   Market Cap 12.19m
Volume 490.08k   Public Float -
* Data may be delayed
1M 3M 6M 1Y 5Y


SUMMARY FINANCIAL STATEMENT INSIDER TRADING PROFILE


COMPANY INFORMATION
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions.

 It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis.

The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California..
INCOME
Calendar Year2024
Revenue0
Cost of Revenue0
Gross Profit0
Gross Profit Ratio0


RELATED NEWS


OUT OF THE BOX TRADING IDEAS SENT STRAIGHT TO YOUR EMAIL!
These "Hot off the Press" alerts on trending stocks are sent straight to your e-mail for ABSOLUTELY FREE!




Sponsored By: Benzinga 26563 People Checked This Out
How To Hit More Winning Option Trades
Dear Reader, There's nothing worse for a new options trader than to… Guess which option trades to enter. Do a bunch of work and still make the wrong picks. And end up wasting a ton of time with little to no gains. But that doesn't have to happen to you. Now you can join Options Starter and get 75% off. Picked for you by Nic Chahine. The Head of Options Trading at Benzinga. Who has one of the best track records we know of… Including recent winning trades like: 90% ROI on JD 511% ROI on AXP 66% ROI on BX As a member of Options Starter you get: 2 hand-picked option trades per month Real-time email or SMS entry & exit alerts Plus a BONUS intro series on option trading For up to 75% off!
Click Here To Get 75% Off Today!


MORE NEWS